Creative Director of The Clueless, Andy Garcia, talks to Metro about how these 'influencers' are created. Top Republicans don't want to talk about the DOJ paying Trump $10 billion Why thousands in ...

DALLAS, March 11, 2026 /PRNewswire/ -- What if luck wasn't random, but something you could engineer? Just in time for St. Patrick's Day, inventor and entrepreneur Julie unveils her new book, Creating ...

SINCE Zara Qairina Mahathir’s tragic death, the whole country is talking about bullying in schools. My heart breaks for the family of the 13-year-old who died last month after a fall from the third ...

Doctors are warning a lack of proper tracking for outsourced medical scans is putting patients at the Royal Hobart Hospital at risk of delayed diagnoses. The Australian Medical Association says the ...

Creating Change Returns to Washington D.C. for 38th Convening for LGBTQ Advocacy In this era of defending LGBTQ rights, the National LGBTQ Task Force invites activists to the 38 th Creating Change.

As far back as 1980, the American philosopher John Searle distinguished between strong and weak AI. Weak AIs are merely useful machines or programs that help us solve problems, whereas strong AIs ...

Some Democrats are looking to create a new think tank in an effort to urge the Democratic Party to promote more popular political positions, Politico first reported on Tuesday. During a private ...

NavLive, a University of Oxford spin-out using AI and LiDAR to create digital twins of buildings for the construction and infrastructure sectors, has closed a £4m funding round. Led by Oxford Capital, ...

What creative person hasn’t spent hard days not managing to get started? For unproductive creatives, these days can stretch into hard weeks, months, and even years. Learning “how to start” and ...

A living fence — one of the most popular garden trends for 2025 — reflects the theme of Nature’s Renaissance, which is Garden Media’s tagline for this gardening year. On the surface, it sounds amazing ...

Glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro and Zepbound have been multibillion-dollar hits for Lilly, and their growth could just be getting started. Lilly is about to enter the ...